Moreover, they are also in line with the results reported in previous investigations, in which increased apoptosis was also demonstrated in different tumor types, including lung cancer cells that were exposed to treatment with PARP inhibitors [41,42,43,44]. Here, PARP1 is linked to lung carcinoma.